Esperion Therapeutics, Inc. 4
4 · Esperion Therapeutics, Inc. · Filed Mar 20, 2015
Insider Transaction Report
Form 4
Lalwani Narendra D.
Chief Operating Officer
Transactions
- Award
Stock option (right to buy)
2015-03-18+20,000→ 20,000 totalExercise: $105.72Exp: 2025-03-18→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]25% of option vests on March 18, 2016 and the remainder shall vest in equal quarterly installments over a three (3) year period thereafter.